More than 95% of the Arkansas residents targeted by the state’s Medicaid work requirement were already working or met the criteria to be exempted from the mandate, according to a study in the New England Journal of Medicine.
While national business groups fight the single-payer concept, the founder and CEO of a large Pennsylvania picture frame manufacturer tries to convince other employers that it’s the only way to control costs and fix the U.S. health system.
Walmart, the nation’s largest private employer, is recommending that employees and dependents use one of 800 imaging centers identified as providing trustworthy care.
Psychiatric treatment for children in Medicaid managed-care plans in Missouri has declined and suicide risks are up, reveals a study sponsored by the state hospital association.
Work helps make people healthier, CMS chief Seema Verma said in approving Utah’s waiver request to tie government health benefits to employment or volunteer work. But Judge James Boasberg has said that isn’t the goal of Medicaid.
The decision applies only to Kentucky and Arkansas, and many experts expect the administration and other conservative states to continue to move forward on rules that would limit coverage for people who don’t work.
Colorado officials say hospitals are better off financially after the state expanded coverage to more low-income residents, but that hasn’t stopped them from shifting more costs to other insured patients.
Varios estados, entre ellos Florida y Nueva York, dijeron que continuarán usando una compañía canadiense para ofrecer a sus empleados medicamentos recetados a bajo precio.
The Food and Drug Administration claims CanaRX, a company used by more than 500 cities, counties and school districts to help their employees get cheaper drugs from overseas, has sent “unapproved” and “misbranded” drugs to U.S. consumers, jeopardizing their safety.
The state’s governor said the plan has the full support of the White House. But the Trump administration was noncommittal about whether allowing states to buy and import cheaper drugs from up north could be the answer to the nation’s drug-pricing problem.